Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$11,945,854
+$1,660,535 QoQ
Shares Held
47,472
+0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#834
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Journey Advisory Group, LLC holds $51,629,041 across 8 Drug Manufacturers - General names. ABBV ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,437 | $25,712,183 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
47,472 | $11,945,854 | |
| 3 | JNJ |
Johnson & Johnson
|
25,892 | $6,575,791 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,149 | $2,974,646 | |
| 5 | AMGN |
Amgen Inc
|
6,427 | $2,327,345 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,141 | $987,664 | |
| 7 | PFE |
Pfizer Inc
|
34,607 | $833,336 | |
| 8 | NVS |
Novartis AG
|
1,737 | $272,222 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,945,854 | 47,472 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $10,285,319 | 47,291 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,984,885 | 48,076 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $11,642,988 | 50,285 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,146,425 | 49,275 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $10,355,106 | 49,423 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,894,062 | 50,051 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $9,884,071 | 50,051 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,584,747 | 50,051 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $9,283,093 | 50,978 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,892,467 | 50,929 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,899,136 | 52,993 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,860,721 | 50,922 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,930,185 | 62,309 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $8,683,305 | 53,730 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $6,327,196 | 47,144 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,830,629 | 44,598 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,062,314 | 25,059 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,879,145 | 21,264 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,008,431 | 18,619 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,904,291 | 16,906 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,673,189 | 15,461 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,599,213 | 14,925 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||